Lieferung
Lieferzeit kann je nach Geschäft und Land abweichen. Lieferrichtlinie, um mehr darüber zu erfahren
Preisspanne
Dr. Reddy's is a multinational pharmaceutical company founded in India in 1984 that manufactures and markets a wide range of pharmaceutical products and active pharmaceutical ingredients (APIs) across the globe.
Founded in 1984 by Dr. Anji Reddy in Hyderabad, India.
Started by manufacturing bulk drugs (APIs) and then expanded into finished dosage forms.
Expanded its international presence by establishing subsidiaries and joint ventures in the US, Europe, and other regions.
Developed a strong generic drug portfolio and became a major player in the US generic market.
Acquired several pharmaceutical companies and products to expand its product range and geographic reach.
A multinational pharmaceutical company based in Israel that specializes in generic and specialty medicines.
A Swiss-based multinational pharmaceutical company that specializes in developing and manufacturing generic pharmaceuticals and biosimilars.
A global pharmaceutical company that specializes in developing, manufacturing, and marketing a wide range of generic and branded pharmaceuticals.
Gastrointestinal
Analgesics
Dermatology
Neurology
Anti-infective
Dr. Reddy's major products include Omez for gastrointestinal disorders, Nise for pain relief, ShinNOVA for psoriasis, Zofer for nausea and vomiting, and Azicip for bacterial infections.
Dr. Reddy's is headquartered in Hyderabad, India.
Dr. Reddy's has a global presence, with products sold in over 100 countries, and offices and facilities in several countries like the US, Europe, Russia, and China.
Dr. Reddy's was founded in Hyderabad, India in 1984 by Dr. Anji Reddy. The company started by manufacturing bulk drugs and then expanded into finished dosage forms. It has since become a major player in the global generic drug market and has acquired several pharmaceutical companies and products over the years.
Dr. Reddy's competitors include multinational pharmaceutical companies like Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, and Mylan NV.
